Literature DB >> 18435804

Establishing humanized mice using stem cells: maximizing the potential.

D Bernard1, M Peakman, A C Hayday.   

Abstract

Studies on physiology and pathology as they relate to the immune system draw heavily upon rodent models. With the increasing impetus provided by initiatives in translational medicine, the demand for ever more sophisticated, 'humanized' murine models is greater than ever. However, the design and implementation of studies in such mice is far from trivial. Here we provide a technical perspective on the increasing interest in developing humanized mice. We give examples of primary data starting with the routine procurement of human donor material, through CD34(+) cell purification prior to engraftment to injection into immunocompromised mice. Our goal is to provide practical advice to the many investigators who may be commencing or considering such studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435804      PMCID: PMC2453213          DOI: 10.1111/j.1365-2249.2008.03659.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  58 in total

1.  Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells.

Authors:  D K Kim; Y Fujiki; T Fukushima; H Ema; A Shibuya; H Nakauchi
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

Review 2.  Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal.

Authors:  B O Roep; M Atkinson
Journal:  Diabetologia       Date:  2004-10-13       Impact factor: 10.122

3.  Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice.

Authors:  Andreina Schoeberlein; Stephan Schatt; Carolyn Troeger; Daniel Surbek; Wolfgang Holzgreve; Sinuhe Hahn
Journal:  Stem Cells Dev       Date:  2004-12       Impact factor: 3.272

4.  Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system.

Authors:  H Kawada; K Ando; T Tsuji; Y Shimakura; Y Nakamura; J Chargui; M Hagihara; H Itagaki; T Shimizu; S Inokuchi; S Kato; T Hotta
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

5.  Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.

Authors:  Miguel Islas-Ohlmayer; Angela Padgett-Thomas; Rana Domiati-Saad; Michael W Melkus; Petra D Cravens; Maria del P Martin; George Netto; J Victor Garcia
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Authors:  Leonard D Shultz; Bonnie L Lyons; Lisa M Burzenski; Bruce Gott; Xiaohua Chen; Stanley Chaleff; Malak Kotb; Stephen D Gillies; Marie King; Julie Mangada; Dale L Greiner; Rupert Handgretinger
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.

Authors:  P A Lowry; L D Shultz; D L Greiner; R M Hesselton; E L Kittler; C Y Tiarks; S S Rao; J Reilly; J H Leif; H Ramshaw; F M Stewart; P J Quesenberry
Journal:  Biol Blood Marrow Transplant       Date:  1996-02       Impact factor: 5.742

Review 8.  Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes.

Authors:  Bart O Roep; Mark Atkinson; Matthias von Herrath
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

9.  Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells.

Authors:  Ramon Gimeno; Kees Weijer; Arie Voordouw; Christel H Uittenbogaart; Nicolas Legrand; Nuno L Alves; Erwin Wijnands; Bianca Blom; Hergen Spits
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

10.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

Authors:  J P Lodolce; D L Boone; S Chai; R E Swain; T Dassopoulos; S Trettin; A Ma
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

View more
  11 in total

1.  Mouse xenograft models vs GEM models for human cancer therapeutics.

Authors:  Ann Richmond; Yingjun Su
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

Review 2.  New cast for a new era: preclinical cancer drug development revisited.

Authors:  Grit S Herter-Sprie; Andrew L Kung; Kwok-Kin Wong
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 3.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

4.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

5.  An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Authors:  Ismail M Meraz; Mourad Majidi; Feng Meng; RuPing Shao; Min Jin Ha; Shinya Neri; Bingliang Fang; Steven H Lin; Peggy T Tinkey; Elizabeth J Shpall; Jeffrey Morris; Jack A Roth
Journal:  Cancer Immunol Res       Date:  2019-06-11       Impact factor: 11.151

Review 6.  Study human pancreatic cancer in mice: how close are they?

Authors:  Yuqing Zhang; Leon Chen; Jingxuan Yang; Jason B Fleming; Paul J Chiao; Craig D Logsdon; Min Li
Journal:  Biochim Biophys Acta       Date:  2012-11-09

Review 7.  Humanized mouse models of HIV infection.

Authors:  Paul W Denton; J Víctor García
Journal:  AIDS Rev       Date:  2011 Jul-Sep       Impact factor: 2.500

8.  Dengue virus markers of virulence and pathogenicity.

Authors:  Rebeca Rico-Hesse
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

9.  Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response.

Authors:  Mattie J Casey; Katarzyna Modzelewska; Daniela Anderson; James Goodman; Elena F Boer; Laura Jimenez; Douglas Grossman; Rodney A Stewart
Journal:  J Vis Exp       Date:  2017-05-17       Impact factor: 1.355

10.  Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

Authors:  T Pearson; L D Shultz; D Miller; M King; J Laning; W Fodor; A Cuthbert; L Burzenski; B Gott; B Lyons; O Foreman; A A Rossini; D L Greiner
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.